SMO and skin basal cell carcinoma: A mechanistic molecular approach to the Hedgehog pathway has led to the discovery of vismodegib, an antagonist of SMO, however, it was later discovered that infiltrative and metastatic BCC could avoid the SMO inhibition which raised suspicions that other signaling pathways may be involved in this process [25,26].